These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4402394)

  • 1. Cytotoxicity in graft-versus-host reaction. I. Role of donor and host spleen cells.
    Singh JN; Sabbadini E; Sehon AH
    J Exp Med; 1972 Jul; 136(1):39-48. PubMed ID: 4402394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic macrophage in graft-versus-host reaction.
    Ptak W; Hanczakowska M; Skowron-Cendrzak A
    Transplantation; 1975 Jan; 19(1):12-9. PubMed ID: 235161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cell-mediated cytotoxicity. I. Augmentation of cell-mediated cytotoxicity induced by radiation.
    Sabbadini E
    J Exp Med; 1974 Aug; 140(2):470-80. PubMed ID: 4846414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunospecific depletion of graft-versus-host-reactive lymphocytes using sensitized syngeneic initiator T lymphocytes.
    Belldegrün A; Cohen IR
    Transplantation; 1979 Nov; 28(5):382-6. PubMed ID: 42999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local graft-versus-host-reaction in mice specifically inhibited by anti-receptor antibodies.
    Binz H
    Scand J Immunol; 1975; 4(1):79-87. PubMed ID: 237319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity in graft-versus-host reaction. II. Lysis of target cells of parental genotyppe by F1 hybrid macrophages.
    Fung KY; Sabbadini E
    Transplantation; 1976 Nov; 22(5):449-54. PubMed ID: 11578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lethal graft-versus-host reaction against non-H-2 antigens. I. Prevention of GVH-associated immunodeficiency by preimmunizing the donor against host-specific non-H-2 antigens.
    Bruley-Rosset M; Pritchard LL; Zohar M; Halle-Pannenko O
    Transplantation; 1989 Apr; 47(4):704-12. PubMed ID: 2523108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for two types of non-specific suppressor cells activated by the graft-versus-host reaction in mice.
    Parthenais E; Lapp WS
    Scand J Immunol; 1978 Mar; 7(3):215-20. PubMed ID: 26111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of nonspecific cytotoxicity in graft-versus-host reaction as a function of target cell type.
    Singh JN; Sabbadini E; Sehon AH
    Cell Immunol; 1973 Aug; 8(2):280-9. PubMed ID: 4146905
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.
    Shand FL
    Immunology; 1975 Dec; 29(6):953-65. PubMed ID: 325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction.
    Iwasaki T; Fujiwara H; Iwasaki T; Shearer GM
    J Immunol; 1986 Nov; 137(10):3100-8. PubMed ID: 2945856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic induction of reticulum cell sarcoma: donor-type lymphomas in the graft-versus-host model.
    Gleichmann E; Peters K; Lattmann E; Gleichmann H
    Eur J Immunol; 1976 Jun; 5(6):406-12. PubMed ID: 10170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M; Sharrow SO; Shearer GM
    J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of self-macrophage-toxic non-T cells in the MHC-homozygous F1 spleen cells co-cultured with parental cells: possible involvements of host cells in impaired immunity in GVH disease.
    Hosono M; Hosokawa T; Fujiwara M; Katsura Y
    Jpn J Exp Med; 1988 Dec; 58(6):261-7. PubMed ID: 2978270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat-mouse radiation chimeras: characterization of an antibody-mediated graft-vs-host reaction.
    Kateley JR; Gengozian N
    J Immunol; 1975 Jan; 114(1 Pt 1):125-32. PubMed ID: 234495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the graft-versus-host reaction by passive immunization of donor against recipient antigens.
    Safford JW; Tokuda S
    Proc Soc Exp Biol Med; 1970 Feb; 133(2):651-4. PubMed ID: 4391839
    [No Abstract]   [Full Text] [Related]  

  • 18. Avoidance of graft versus host reactions in cured W-anemic mice.
    Harrison DE
    Transplantation; 1976 Jul; 22(1):47-51. PubMed ID: 7035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy among lymphoid cells mediating the graft-versus-host response. V. Derivation by migration in lethally irradiated recipients of two interacting subpopulations of thymus-derived cells from normal spleen.
    Tigelaar RE; Asofsky R
    J Exp Med; 1973 Feb; 137(2):239-53. PubMed ID: 4405532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.
    Van Elven EH; Rolink AG; Veen FV; Gleichmann E
    J Exp Med; 1981 Jun; 153(6):1474-88. PubMed ID: 6454750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.